Ranking highlights Genpact's outstanding global delivery and AI capabilities, including advanced digital and AI solutions across regulatory and medical affairs value chain
Genpact, a global professional services and solutions firm delivering outcomes that shape the future, has been recognized as a Leader in the Everest Group Life Sciences Regulatory and Medical Affairs...
Agilisium, a pioneering leader in Data Analytics, Cloud, and Life Science solutions, announced that it has won the coveted AWS Life Sciences Competency status; placing the brand among an exclusive group of 28 Consulting Partners out of 8,300+ AWS Partners globally. This remarkable achievement demonstrates the company's proven expertise...
Agilent Technologies Inc announced it has acquired Sigsense Technologies, a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operations. Financial terms of the acquisition were not disclosed.
Sigsense technology is already available to Agilent customers through CrossLab Connect, a suite of digital applications—inventory management, service...
Medidata , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced that Eisai Inc, the U.S. pharmaceutical subsidiary of Eisai Co., Ltd. (Headquartered in Tokyo) , has become one of the first customers to adopt the recently released AI-driven Medidata Clinical Data Studio . Eisai...
eLabNext, a leading provider of digital lab management solutions, and ABI-LAB, a premier life sciences incubator located in Natick, MA, have announced a strategic alliance aimed at driving innovation and supporting the growth of life sciences startups.
Under this pioneering collaboration, eLabNext will provide cutting-edge digital lab management solutions to the ventures...
BullFrog AI Holdings, Inc., a leader in AI-driven drug discovery, announced significant advancements in its ongoing collaboration with the Lieber Institute for Brain Development (LIBD). Building on the progress detailed in our May 16, 2024 release, our research has now pinpointed specific molecular pathways associated with bipolar disorder (BD),...
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced a strategic partnership with WeComput to jointly advance the construction and improvement of Innovent Biologics' Artificial Intelligence for Drug Discovery...
Deep 6 AI, the leader in AI-powered patient recruitment and real-world data (RWD), announced the appointment of Doug Cassidy as president of its Precision Research Ecosystem. The Deep 6 AI Ecosystem is the largest network of health systems and life sciences companies, enabling over 45 member organizations to de-risk and accelerate clinical...
Prevencio, Inc., a leader in AI-powered blood tests for cardiovascular diagnostics, announces that the United States Patent and Trademark Office has issued a patent for its highly accurate blood test, HART CADhs, which assesses a patient’s risk of obstructive coronary artery disease, also referred to as obstructive heart disease. The...
Exai to accelerate product development and partnering of its novel oncRNA- and generative AI-based liquid biopsy platform
Exai Bio, a next-generation oncRNA- and generative AI-based liquid biopsy company, announced the appointment of Dave Daly as Chief Executive Officer. With more than 30 years of cancer diagnostics and executive leadership experience,...
